FUNDAMENTALS · Fundamentals · AU Industrials

McMillan Shakespeare (MMS) Fundamentals 2026 — P/E 13.7x, Revenue Analysis | SniperIQ

McMillan Shakespeare (MMS) is a AU-listed Industrials company in Staffing & Employment Services with a market capitalization of A

.4B, trading at A
9.52 on the ASX. This SniperIQ fundamentals page covers McMillan Shakespeare's valuation (P/E 13.7x, P/B 12.1x), profitability (net margin 17.8%), revenue (A$436M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapA
.4B
P/E (TTM)13.7x
Net Margin17.8%
Revenue (FY25)A$436M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is McMillan Shakespeare's market cap?

McMillan Shakespeare (MMS) has a market capitalization of approximately A

.4B, trading at A
9.52 on the ASX. Market cap moves with the live share price.

What is McMillan Shakespeare's P/E ratio?

McMillan Shakespeare's trailing twelve-month P/E ratio is 13.7x, with a price-to-book (P/B) of 12.1x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.

How profitable is McMillan Shakespeare?

McMillan Shakespeare runs a net profit margin of 17.8%, a gross margin of 49.2%, and an operating margin of -2.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does McMillan Shakespeare generate?

McMillan Shakespeare reported revenue of A$436M for fiscal year 2025, with net income of A$95M and earnings per share (EPS) of 1.37. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does McMillan Shakespeare pay a dividend?

McMillan Shakespeare offers a trailing dividend yield of about 7.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is McMillan Shakespeare financially healthy?

McMillan Shakespeare carries a debt-to-equity ratio of 7.57x and a current ratio of 1.13x, with a market beta of 0.69. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is McMillan Shakespeare a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For McMillan Shakespeare (MMS) the key facts are: market cap A

.4B, P/E 13.7x, revenue A$436M, 52-week range 13.525-20.14. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.

Track McMillan Shakespeare's full fundamentals live

Get McMillan Shakespeare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Sundart Holdings (1568) fundamentals · Pacific Textiles Holdings (1382) fundamentals · Capital Clean Energy Carriers (CCEC) fundamentals · Nordic American Tankers (NAT) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons